c-MYC
Use
c-MYC is a proto-oncogene that produces short-lived nuclear phosphoprotein. Overexpression of c-MYC is implicated in the etiology of a variety of hematopoietic tumors. Dual overexpression of BCL2 and MYC oncoproteins is associated with unfavorable outcomes in diffuse large B cell lymphoma (DLBCL).
Special Instructions
Not provided.
Limitations
The performance and interpretation of results may be influenced by the pre-analytical variables, such as specimen handling, fixation time, or tissue source. Certain factors, like improper handling or suboptimal fixation, may lead to inaccurate or non-reproducible results.
Methodology
Immunoassay (IHC)
Biomarkers
c-MYC
Protein
Result Turnaround Time
2 days
Related Documents
For more information, please review the documents below
Specimen
Tissue (Fixed (Non-FFPE))
Volume
Not provided
Minimum Volume
Not provided
Container
Fresh Tissues: Fixative should be at a 20:1 fixative to tissue ratio, 10% neutral buffered formalin (NBF) for 6-72 hours (48-72 hours PREFERRED)
Storage Instructions
15°C to 25°C
Causes for Rejection
Specimens must be fixed in 10% NBF or B plus. All other fixatives will be rejected.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | ≤ 72 Hours |